...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Almost 1.25 years now

....Perhaps there actually is some merit in Don's apparent exuberance when he talked to GAC about Zenith being sold in the next 2 to 3 months. One month has going by since that discussion at B & B so that leaves June and July for the sale....

I wouldn't take it too literally.  IMO, in that context, 2-3 means at least 6.

Share
New Message
Please login to post a reply